Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-07-27 / Pigment Cell Melanoma Res 2010 Oct;23(5):607-19The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2010-01-01 / J. Virol. 2010 Jan;84(1):639-46Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-15Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer
/in Dendritic Cells, International Publications, Malignant Melanoma, Prostate Cancer /von 2009-06-15 / Prostate 2009 Jun;69(9):938-48Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-05-07 / J. Clin. Immunol. 2009 Sep;29(5):657-64Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-05-05 / Clin. Cancer Res. 2009 May;15(10):3366-75Melanoma vaccines: The problems of local immunosuppression
/in International Publications, Malignant Melanoma /von 2009-05-01 / Hum. Immunol. 2009 May;70(5):331-9Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-03-24 / Clin. Cancer Res. 2009 Apr;15(7):2531-40
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution